Task variability/correlations decrease independently of mean task activity removal step in fMRI data. by Takuya Ito (57473)

Complication rates. by Hyun Soo Bae (15411910)

Subjects:

Elevated concentrations of serum MMA among participants with decreased cognitive performance. by Yige Liu (11940344)

Depleted antibody secreting cells did not result in decreased donor specific antibody in non-sensitized animals. by Natalie M. Bath (6316517)

“…(A) T (CD3⁺) and (B) B (CD45R⁺) cell flow crossmatch was performed in non-sensitized animals. IgG1⁺ in the T cell flow crossmatch was the only DSA that BLyS^-/- significantly decreased compared to APRIL^-/- (p<0.03). …”

Treatment with pan-PKC inhibitor Gö-6983 resulted in a non-significant decrease in <i>GRK6</i> promoter activity. by Maike Stegen (8578665)

Surgical outcome and complication rates. by Timur Shamshudinov (12225685)

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

Homozygous microdeletions of SNPs in the rs58923657 non-risk haplotype result in significantly decreased <i>IKZF1</i> expression and increased proliferation in human LCLs. by Vincent U. Gant (9955199)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

CFU-Mk is significantly decreased by GATA1s overexpression in <i>GATA1s</i> strains. by Shiori Matsuo (10492159)

Comparison of complication rates between groups. by Diego T. Dias (3151332)

Forest plot of complication rates. by Yuxian Chen (7551833)

“…At the final follow-up for ODI, the DF group demonstrated statistically superior outcomes compared to the DA group (MD = 1.28, 95%CI 0.35, 2.21, <i><i>P</i> </i>= 0.007). Data revealed no significant differences in SF12-PCS, JOA score, back pain VAS score, leg pain VAS score, final follow-up EQ-5D, reoperation rates, complication rates, and Odom’s criteria (<i><i>P</i> </i>> 0.05).…”

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Trial sequential analysis (TSA) for complication rate. by Kuo-Chuan Hung (8587392)

Subjects:

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

(A) The incidence of OME in the VA group compared to the non-VA group. (B) The rate of tympanostomy tube insertion in the VA group and non-VA group. by Miki Kashiwagi (21439684)

Impaired Ubr5 function results in increased canonical and decreased non-canonical HH signalling. by David Mellis (2833469)

Most significant muscle activation values. by María Benito-de-Pedro (22057468)

Subjects:

Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Homozygous deletion of the orthologous murine <i>Ikzf1</i> enhancer results in significantly decreased <i>Ikzf1</i> expression, increased cell proliferation, and altered B cell dif... by Vincent U. Gant (9955199)